[Research Progress on the Role of Dendritic Cells in Immune Metabolism of Rheumatoid Arthritis]

Overview

Journal Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi

Specialty General Surgery

Date 2024 Dec 18

PMID 39694847

Authors

Guangtao Han

Shuo Sun

Qin Wang

Pengde Kang

Affiliations

Soon will be listed here.

Abstract

Objective: To review the role of dendritic cells (DC) in immune metabolism of rheumatoid arthritis (RA).

Methods: Literature on the role of DC in the immune metabolism of RA was extensively reviewed in recent years, and the metabolic characteristics of RA, the role of DC in RA, the correlation between the immune metabolism of DC and pathogenesis of RA, and the treatment were summarized and analyzed.

Results: DC promotes the progression of RA under hypoxia, increased glycolysis, inhibition of oxidative phosphorylation, and decreased lipid metabolism. Moreover, many DCs (especially conventional DC and monocyte-derived DC) have different functions and phenotypic characteristics in RA, which are closely related to the occurrence and development of RA.

Conclusion: DC plays an important role in the immune metabolism of RA, and immunometabolism therapy based on DC can provide targeted therapy for the treatment of RA.

References

Cooles F, Anderson A, Skelton A, Pratt A, Kurowska-Stolarska M, McInnes I . Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis. Front Immunol. 2018; 9:755. PMC: 5968398. DOI: 10.3389/fimmu.2018.00755. View

Canavan M, Marzaioli V, McGarry T, Bhargava V, Nagpal S, Veale D . Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells. Clin Exp Immunol. 2020; 202(2):226-238. PMC: 7597596. DOI: 10.1111/cei.13479. View

Jia X, Chang Y, Sun X, Dai X, Wei W . The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritis. Int Immunopharmacol. 2014; 23(1):163-9. DOI: 10.1016/j.intimp.2014.08.024. View

Tian Y, Shi P, Zhou Y, Yuan R, Hu Z, Tan Y . DiR-labeled tolerogenic dendritic cells for targeted imaging in collagen- induced arthritis rats. Int Immunopharmacol. 2020; 91:107273. DOI: 10.1016/j.intimp.2020.107273. View

Qiao H, Mei J, Yuan K, Zhang K, Zhou F, Tang T . Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles. J Nanobiotechnology. 2022; 20(1):323. PMC: 9281050. DOI: 10.1186/s12951-022-01536-0. View

Ah Kioon M, Laurent P, Chaudhary V, Du Y, Crow M, Barrat F . Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity. Immunol Rev. 2024; 323(1):241-256. DOI: 10.1111/imr.13331. View

Zhou S, Lu H, Xiong M . Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis. Front Immunol. 2021; 12:726747. PMC: 8411707. DOI: 10.3389/fimmu.2021.726747. View

Calabresi E, Petrelli F, Bonifacio A, Puxeddu I, Alunno A . One year in review 2018: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2018; 36(2):175-184. View

Feng X, Chen Y . Drug delivery targets and systems for targeted treatment of rheumatoid arthritis. J Drug Target. 2018; 26(10):845-857. DOI: 10.1080/1061186X.2018.1433680. View

10.

Spiering R, Jansen M, Wood M, Fath A, Eltherington O, Anderson A . Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis. J Transl Med. 2019; 17(1):375. PMC: 6857208. DOI: 10.1186/s12967-019-2128-4. View

11.

Zhou Y, Leng X, Luo S, Su Z, Luo X, Guo H . Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance. J Immunol Res. 2017; 2016:5021537. PMC: 5187469. DOI: 10.1155/2016/5021537. View

12.

Wang J, Xue Y, Zhou L . Comparison of immune cells and diagnostic markers between spondyloarthritis and rheumatoid arthritis by bioinformatics analysis. J Transl Med. 2022; 20(1):196. PMC: 9066892. DOI: 10.1186/s12967-022-03390-y. View

13.

Geng Q, Xu J, Cao X, Wang Z, Jiao Y, Diao W . PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis. J Autoimmun. 2024; 146:103214. DOI: 10.1016/j.jaut.2024.103214. View

14.

Abdallah M, Alarfaj S, Saif D, El-Naggar M, Elsokary M, Elsawah H . The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. Int Immunopharmacol. 2021; 95:107575. DOI: 10.1016/j.intimp.2021.107575. View

15.

Lee E, Sul J, Shin J, Shin S, Lee J, Kim H . Reactive oxygen species-responsive dendritic cell-derived exosomes for rheumatoid arthritis. Acta Biomater. 2021; 128:462-473. DOI: 10.1016/j.actbio.2021.04.026. View

16.

Moudgil K, Venkatesha S . The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation. Int J Mol Sci. 2023; 24(1). PMC: 9820125. DOI: 10.3390/ijms24010095. View

17.

Papadaki G, Goutakoli P, Tiniakou I, Grun J, Grutzkau A, Pavlopoulos G . IL-6 Signaling Attenuates TNF-α Production by Plasmacytoid Dendritic Cells in Rheumatoid Arthritis. J Immunol. 2022; 209(10):1906-1917. DOI: 10.4049/jimmunol.2100882. View

18.

Marzaioli V, Canavan M, Floudas A, Flynn K, Mullan R, Veale D . CD209/CD14 Dendritic Cells Characterization in Rheumatoid and Psoriatic Arthritis Patients: Activation, Synovial Infiltration, and Therapeutic Targeting. Front Immunol. 2022; 12:722349. PMC: 8789658. DOI: 10.3389/fimmu.2021.722349. View

19.

Gan P, Wu H, Zhu Y, Shu Y, Wei Y . Glycolysis, a driving force of rheumatoid arthritis. Int Immunopharmacol. 2024; 132:111913. DOI: 10.1016/j.intimp.2024.111913. View

20.

Garcia-Hernandez M, Rangel-Moreno J, Garcia-Castaneda M, Kenney H, Paine A, Thullen M . Dendritic cell-specific transmembrane protein is required for synovitis and bone resorption in inflammatory arthritis. Front Immunol. 2022; 13:1026574. PMC: 9677122. DOI: 10.3389/fimmu.2022.1026574. View